Hématologie
Volume 25, supplement 2, Juin 2019
La maladie résiduelle : quelles indications et quelles utilisations en 2019 ?
Volume 25, supplement 2, Juin 2019
Revues
Role of minimal residual disease in the management of acute myeloid leukaemias
(p.3-16)
Claude Preudhomme
Free Access
Relevance of MRD in CLL: recent data and role of combinations
(p.17-23)
Anne Quinquenel
Free Access
Determination of residual disease by flow cytometry in chronic lymphocytic leukemia: state of play of technical practices and prospects
(p.24-35)
Rémi Letestu, Magali Le Garff-Tavernier
Free Access
Minimal residual disease for multiple myeloma
(p.36-9)
Hervé Avet-Loiseau, Jill Corre
Free Access